Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control

Abstract Objectives: This study examines the association between changes in diabetes-related quality measures (QMs) (HbA1c, systolic and diastolic blood pressure [BP], low-density lipoprotein cholesterol [LDL-C], and body weight) and healthcare costs in Type 2 diabetes mellitus (T2DM) patients. It a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical economics 2015-02, Vol.18 (2), p.113-125
Hauptverfasser:	Lafeuille, Marie-Hélène, Grittner, Amanda Melina, Gravel, Jonathan, Bailey, Robert A, Martin, Silas, Garber, Lawrence, Duh, Mei Sheng, Lefebvre, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Blood Glucose Blood Pressure Body Weight Canagliflozin Canagliflozin - economics Canagliflozin - therapeutic use Cholesterol, LDL Comorbidity Computer Simulation Costs and Cost Analysis Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female Glycated Hemoglobin A HbA1c Healthcare costs Humans Hypoglycemic Agents - economics Hypoglycemic Agents - therapeutic use Insurance Claim Review LDL-C Male Middle Aged Models, Econometric Quality Indicators, Health Care Sitagliptin Sitagliptin Phosphate - economics Sitagliptin Phosphate - therapeutic use Type 2 diabetes mellitus Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!